Elektrofi

We're #hiring a new Engineer III in Boston, Massachusetts. Apply today or share this post with your network.

A mission-driven approach and unwavering focus will get you to your goal every time! It’s incredible to see what a dedicated team can accomplish when they're aligned with purpose and committed to growth. Here’s to even greater milestones ahead! ?? #MissionDriven #Focus #Growth

We're #hiring a new Senior Engineer in Boston, Massachusetts. Apply today or share this post with your network.

We’re thrilled to see Elektrofi up in lights in Times Square! Thank you, Nasdaq, for the warm congratulations on our oversubscribed $112.25 Million Series C closing. This milestone brings us one step closer to revolutionizing subcutaneous drug delivery. #Elektrofi #SeriesC #Biotech #Biologics Novo Holdings, RA Capital Management, Royalty Pharma, SR One Capital Management, TPG

We envision a world in which patients are untethered from the burdens and limitations associated with traditional biologic administration. With the successful close of our oversubscribed $112.25 Million Series C Financing, we are one step closer to making that vision a reality. This funding strengthens our capacity to build a second GMP line that is commercial-scale and will further accelerate clinical development across our expanding portfolio of collaboration products. https://lnkd.in/eEAdngZs

Thrilled to have been recognized on the floor of the NYSE as we celebrated the closing of our oversubscribed $112.25 Million Series C. For more than eight years, our scientists and engineers have been pushing the boundaries and expanding new frontiers in subcutaneous medicine deliver. Today, with our team of experts, investors, and trusted partners, we are excited to scale our Hypercon? microparticle platform technology, expand our operations, and continue pushing the boundaries of what's possible in biopharmaceutical formulation technology. #NYSE #Elektrofi #SeriesC #HealthcareInnovation #Milestones Novo Holdings, RA Capital Management, Royalty Pharma, SR One Capital Management, TPG https://lnkd.in/eEAdngZs

Elektrofi Announces Oversubscribed $112.25 Million Series C Financing to Establish Commercial-Scale GMP Manufacturing Capacity & Accelerate Clinical Development Across its Growing Portfolio of Partnered Programs ? This funding reflects Elektrofi’s leadership position in drug delivery, as well as the promise of Hypercon?, a broadly applicable platform for the hyper concentration and stabilization of biopharmaceuticals.?Proceeds from the financing will be used, in part, to establish Ph3 and commercial-scale GMP manufacturing capacity that will accelerate clinical development and provide global support for a growing portfolio of partnered programs. ? We are grateful for the strong support from our distinguished group of co-lead investors #NovoHoldings, #RACapitalHealthcareFund, #RoyaltyPharma, #SROne, #TPG. ? Cheers to ushering in an era of patient-centered care in collaboration with our forward-thinking investors and pharma partners. Together we are Formulating the Future of Biologics?.

We're #hiring a new Senior Coordinator, Logistic and Distribution in Boston, Massachusetts. Apply today or share this post with your network.

We're #hiring a new Scientist, Analytical Development in Boston, Massachusetts. Apply today or share this post with your network.

We're #hiring a new Executive Director, Head of Manufacturing Science and Technology in Boston, Massachusetts. Apply today or share this post with your network.